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ABSTRACT
Alzheimer’s disease (AD) is the most common cause of dementia, which generally affects people over 65 years old. Some genetic 
mutations induce early onset of AD and help to track the evolution of the symptoms and the physiological changes at different 
stages of the disease. In Colombia there is a large family group with the PSEN1 E280A mutation with a median age of 46,8 years 
old for onset of symptoms. AD has been defined as a disconnection syndrome; consequently, network approaches could help to 
capture different features of the disease. The aim of the current work is to identify a biomarker in AD that helps in the tracking of the 
neurodegenerative process. Electroencephalography (EEG) was recorded during the encoding of visual information for four groups of 
individuals: asymptomatic and mild cognitive impairment carriers of the PSEN1 E280A mutation, and two non-carrier control groups. 
For each individual, the effective connectivity was estimated using the direct Directed Transfer Function and three measurements 
from graph theory were extracted: input strength, output strength and total strength. A relation between the cognitive status and age 
of the participants with the connectivity features was calculated. For those connectivity measures in which there is a relation with 
the age or the clinical scale, the performance as a diagnostic feature was evaluated. We found that output strength connectivity in 
the right occipito-parietal region is related to age of the carrier groups (r = −0,54, p = 0,0036) and has a high sensitivity and high 
specificity to distinguish between carriers and non-carriers (67 % sensitivity and 80 % specificity in asymptomatic cases, and 83 % 
sensitivity and 67 % specificity in symptomatic cases). This relationship indicates that output strength connectivity could be related 
to the neurodegenerative process of the disease and could help to track the conversion from the asymptomatic stage to dementia.
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RESUMEN
La enfermedad de Alzheimer (EA) es la causa más común de demencia, la cual afecta generalmente a personas después de los 65 años 
de edad. Algunas mutaciones genéticas inducen la aparición temprana de EA ayudando a monitorear la evolución de los síntomas y 
los cambios fisiológicos en diferentes etapas de la enfermedad. En Colombia existe un gran grupo familiar con la mutación PSEN1 
E280A, con una edad media de aparición de los síntomas de 46,8 años. La EA ha sido definida como un síndrome de desconexión; 
en consecuencia, enfoques de redes podrían ayudar a capturar diferentes características de la enfermedad. El objetivo del presente 
trabajo es identificar un biomarcador en la EA que permita realizar el seguimiento del proceso neurodegenerativo. Se registró una 
electroencefalografía (EEG) durante la codificación de información visual en cuatro grupos de sujetos: portadores de la mutación PSEN1 
E280A asintomáticos y con deterioro cognitivo leve y dos grupos control de no portadores. Para cada sujeto se estimó la conectividad 
efectiva utilizando la Función de Transferencia Directa dirigida y se extrajeron tres medidas de grafos: fuerza de entrada, fuerza de salida 
y fuerza total. Se calculó una relación entre el estado cognitivo y la edad de los participantes con las características de conectividad. 
Para aquellas medidas de conectividad que tuvieran una relación con la edad o la escala clínica, se evaluó su desempeño como variable 
de diagnóstico. Se encontró que la fuerza de conectividad saliente en la región parieto-occipital derecha está relacionada con la edad 
del grupo de los portadores (r = −0,54, p = 0,0036), y que tiene alta sensibilidad y especificidad para distinguir entre portadores y no 
portadores (67 % de sensibilidad y 80 % de especificidad en casos asintomáticos, y 83 % de sensibilidad y 67 % de especificidad en casos 
sintomáticos). Esta relación indica que la fuerza de conectividad saliente podría estar relacionada con el proceso neurodegenerativo de 
la enfermedad y podría ayudar a realizar un seguimiento de la conversión desde la etapa asintomática hacia la demencia.
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Introduction
Alzheimer’s disease (AD) is the most prevalent cause of 
dementia, a neurodegenerative condition which generally 
affects people over 65 years old (Minati, Edginton, 
Bruzzone, & Giaccone, 2009). Although it is impossible 
to know which individuals will develop AD, some genetic 
mutations induce the early onset of the disease (Bertram 
& Tanzi, 2011) helping to follow the evolution of the 
symptoms and the physiological changes in early stages 
of the disease. In Colombia there is a large family group 
with the PSEN1 E280A mutation which is involved in 
the production of β-amyloid (Lopera et al., 1997). The 
symptoms onset occurs at a median age of 46,8 years old 
(Ardila et al., 2000). Given that the efficacy of some AD 
therapies may depend on the initiation of treatment before 
the onset of clinical symptoms, it is important to search for 
early biomarkers. Nowadays, the study of mutation carriers 
provides the unique opportunity to identify early changes 
related to predisposition to the disease (Langbaum et al., 
2013; Sperling, Mormino, & Johnson, 2014).
Electroencephalography (EEG) enables the investigation 
of early neurophysiological changes associated with 
neurodegenerative processes. It represents a low cost, 
portable and non-invasive alternative to study brain 
functions (Micanovic & Pal, 2014). AD has been defined 
as a disconnection syndrome and consequently, network 
approaches based on graph theory have captured 
different features of the disease (Bullmore & Bassett, 
2011; Hafkemeijer, van der Grond, & Rombouts, 2012; 
He, Chen, Gong, & Evans, 2009; Ouchi & Kikuchi, 2012; 
Xie & He, 2011). EEG studies show that brain activity 
synchronization is disturbed in AD (Pievani, de Haan, 
Wu, Seeley, & Frisoni, 2011). Increases in delta and 
theta activity and decreases in coherence between brain 
regions have been reported (Hsiao, Wang, Yan, Chen, & 
Lin, 2013). Studies have shown that functional networks 
in AD lose their normal small-world structure, and evolve 
towards a more random architecture (Sanz-Arigita et al., 
2010; Supekar, Menon, Rubin, Musen, & Greicius, 2008). 
An increased vulnerability of the brain network hubs to 
the accumulation of β-amyloid has also been found (Stam 
et al., 2009). 
Recent studies using magnetic resonance imaging in 
PSEN1 E280A mutation carriers have demonstrated 
preclinical changes in thickness and volume across the 
cortex (Yakeel T Quiroz et al., 2013). Changes have also 
been shown in regional brain activity using positron 
emission tomography (Fleisher et al., 2015), functional 
magnetic resonance imaging (Yakeel T Quiroz et al., 
2010), spectral energy alterations in EEG, and potential 
modulation in event related potentials studies (Bobes et 
al., 2010; Duque-Grajales et al., 2014; Y T Quiroz et al., 
2011; Rodriguez et al., 2014; Tobon et al., 2015). These 
findings show the disease to be a dynamical phenomenon 
(Y T Quiroz et al., 2011). To our knowledge, there are no 
studies on how the effective connectivity in the PSEN1 
E280A mutation can help to differentiate pre-symptomatic 
and symptomatic AD PSEN1 E280A mutation carriers 
from non-carriers using EEG signals. We hypothesized that 
patients with the mutation have altered network features 
compared with control subjects, and this alteration could 
be used as a biomarker.
The aim of the current work is to identify EEG effective 
connectivity features that might serve as possible biomarkers 
in AD. Given that AD is a neurodegenerative process, the 
identified features should change across different years, 
following the pattern of neurodegeneration. Therefore, 
we recorded EEG during the performance of a memory 
encoding task for four groups of individuals: asymptomatic 
carriers of the PSENI E280A mutation, mutation carriers 
with mild cognitive impairment (MCI) and two non-carrier 
control groups. For each individual we evaluated the 
effective connectivity using the direct Directed Transfer 
Function (dDTF) (Delorme et al., 2011). Then, we developed 
a statistical analysis to find a relationship between 
connectivity measures and age and cognitive status, and 




The subjects were members of the PSEN1 E280A mutation 
Colombian kindred. Fifteen asymptomatic mutation carriers 
(ACr) without cognitive impairment, twelve participants 
with MCI, and twenty-seven healthy non-carriers were 
matched for gender, age, and educational level with ACr 
group (Control1), and MCI group (Control2) (Table 1). 
Due to the difference in age between asymptomatic and 
symptomatic carriers groups, two control groups were 
selected. For AD the age is a critical factor and the subjects 
with clinical complaints are not comparable with younger 
subjects. Informed consent for participation was obtained 
from all subjects according to the protocol approved by 
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the Human Subjects Committee of the Universidad de 
Antioquia. In addition to the EEG records, neurological 
and neuropsychological tests were performed (Aguirre-
Acevedo et al., 2007). All data were acquired by researchers 
who were blinded to the participant’s genetic status. The 
exclusion criteria were severe physical illness, alcohol/
drugs abuse, regular use of neuroleptics and antidepressants 
with anticholinergic action.
EEG recordings
A Neuroscan unit amplifier (Neuroscan Medical System, 
Neuro-soft Inc. Sterling, VA, USA) was used to record 
EEG signals. EEG data were recorded from 64 electrodes 
positioned according to the international 10-10 system 
with midline reference (recomputed to common average). 
The signal was digitized at a sampling rate of 1000 Hz 
and filtered online (bandpass filter: 0,05 to 200 Hz, and 
band reject filter 60 Hz to eliminate noise from the power 
supply). A simultaneous electrooculogram (0,1 ± 100 Hz 
bandpass) was also recorded. Recordings were obtained 
while subjects performed a memory encoding task using 
color pictures of concrete and nameable objects (Figure 
1). This task is based on a paradigm previously used in 
the same population (Y T Quiroz et al., 2011). 50 stimuli 
were presented. Each trial begins with a 1000 ms fixation 
character (“+”) prior to the presentation of the stimuli. 
Then, stimuli were presented for 2000 ms followed by 
the question, “Do you like this item?” Subjects were then 
prompted to press a button to signify their like/dislike 
judgment.
Table 1. Demographic and neuropsychological characteristics of 
participants.
































































22,2 (±4,6) 29,4 (±1,2)
T = −5,17
df = 12,37
P = 2 × 10-4
ACr: asymptomatic mutation carriers; MMSE: mini-mental state exami-
nation; SD: standard deviation; df: degrees of freedom; X2: chi-squared.
Figure 1. Scheme of memory encoding paradigm used.
Signal pre-processing
EEG data were analyzed offline for artifact correction 
from the implementation of an automated preprocessing 
pipeline using MATLAB toolbox EEGLAB (Delorme 
& Makeig, 2004). Data were filtered (1–50 Hz; FIR 
filter), bad channels were detected and interpolated 
using spherical splines. Then, data were segmented in 
epochs of 1 s, selected after stimulus presentation, and 
re-referenced to average. The EEG epochs with ocular, 
muscular, and other kinds of artifact were removed by 
a computerized automatic procedure based on linear 
trend, joint probability and kurtosis approach (Delorme, 
Sejnowski, & Makeig, 2007). Independent component 
analysis enhanced by wavelet was used to correct eye 
blinks artifacts (Castellanos & Makarov, 2006). The last 
method applies a wavelet thresholding to the demixed 
independent components as an intermediate step, 
which enables recovering the neural activity present in 
artefactual components. In this case, we use a threshold of 
0,1, which represents the probability that the component 
was neuronal. This probability was calculated by the 
Multiple Artifact Rejection Algorithm (Winkler, Haufe, & 
Tangermann, 2011).
Data were resampled to 200 Hz and used to calculate 8 
regions of interest (ROI’s) as the average of channels in each 
ROI (Figure 2). These regions correspond to frontal, parietal 
and occipital areas of each hemisphere. 
Figure 2. Electrode distribution according to 10-10 system used in the 
recording of the EEG data and ROI’s calculated (Oostenveld & Praam-
stra, 2001).
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Direct Directed Transfer Function and Graph 
construction
For each subject, a sliding-window Adaptive Multivariate 
Autoregressive (AMVAR) model was fitted to the 1 s time 
series, where the time series correspond to the signal 
in each ROI. The dDTF was estimated using the Source 
Information Flow Toolbox (Delorme et al., 2011). The 
length of the sliding-window was 250 ms with a window 
step of 10 ms. The parameters used to fit the model are 
shown in Table 2.
Table 2. AMVAR model parameters
Parameter Value
Model Order 9,24 ± 1,15
Window step 0,01 s
Window length 0,25 s
Consistency (74,48 ± 10,58) %
Stability 100 %
Mean ± standard deviation.
In each sliding-window the dDTF is calculated as follows:
 d ij
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( f )= n ij
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Where f is the frequency, nij
2 f( ) is the full frequency DTF 
(ffDTF) (Equation (2)), kij
2 f( ) is the partial coherence (Equation 
(3)), Hij is the system transfer matrix obtained after the 
z-transform of the AMVAR model, and S f( )  is the spectral 
density matrix. Indices i, j refer to signals in ROIs i and j.
The dDTF was analyzed in alpha1 frequency band 
(8–10 Hz), which is related to memory processes (Klimesch, 
Freunberger, & Sauseng, 2010), for time widows of 100 ms 
along each 1 s epoch. At each interval, an 8×8 matrix 
was obtained where each entry (i,j) correspond to the 
connectivity between the ROI-i and the ROI-j. 
The new matrices were normalized according to the 
recommendations given by Ahnert et al. (Ahnert, 
Garlaschelli, Fink, & Caldarelli, 2007), to avoid the definition 
of a threshold for the comparison between groups. Three 
graphs measures were obtained: total strength, in-strength, 
and out-strength (Rubinov & Sporns, 2010). Total strength is 
the sum of weights of links connected to the node:
 ki






p  is the node strength, N is the set of all nodes in 
the network and Pji  are the connection weights between 
node i and j. In-strength is the sum of inward link weights 
and out-strength is the sum of outward link weights. 
Statistical analysis
Given that the main motivation of this study is to identify 
a biomarker in EEG connectivity features that allows 
the tracking of the neurodegenerative process, the first 
step was a correlation analysis of each connectivity 
measurement with age and MMSE in the carriers (ACr 
and MCI) and non-carriers (Control1 and Control2). This 
analysis was conducted for each ROI separately trying 
to find regions where the connectivity was related to the 
age or the neuropsychological scale. The performance of 
the measurements as diagnostic variables were quantified 
by calculating the area under the receiver operating 
characteristic curves (AUROC). In view of differences in 
age in these groups (p = 0,05), data were corrected for this 
variable using linear regression. 
Results
There were no differences in gender, education or 
neuropsychological examination between ACr and 
Control1 (Table 1) as were expected, because of the 
asymptomatic condition of this groups. We found 
differences in MMSE examination between MCI patients 
and Control2 subjects. Regarding behavioral data, there 
were no significant differences between ACr and Control1 
for reaction time (p > 0,1). Comparing MCI and Control2 
groups, MCI group has a longer reaction time (p < 0,05) 
and a lower recognition score after the encoding stage 
(p < 0,05).
No significant correlations for measures of in-strength and 
total strength were found in any ROI. Only a significant 
correlation for out-strength was found. Table 3 shows 
the correlation analysis results between out-strength 
connectivity and age, and out-strength connectivity and 
MMSE. This measure had significant correlation only for the 
carriers group in ROI7. In the non-carriers group there were 
no significant associations. 
Figure 3 shows plots of out-strength mean in ROI7 for 
the groups across the ten time windows defined in the 
methodology. It shows a variation of the measurement 
along the time for each group and a difference in values 
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among the groups. Since the data does not meet the 
assumptions for analysis of variance, we chose to use 
measures of effect size to calculate the magnitude of 
the difference between the groups, using the Hedges’ g 
(standardized mean difference) (Hentschke & Stüttgen, 
2011) in each time interval. The results showed a higher 
out-strength for ACr group compared with Control1 on 
600 ms (Hedges = 0,698, CI = 0,015 – 1,595), and 800 ms 
(Hedges = 0,742, CI = 0,097 − 1,402). Also, decreased out-
strength for MCI group compared to Control2 was found 
on 600 ms (Hedges = −0,872, CI = −1,640 – (−0,209).
Discussion
In this work we studied the relationship between 
connectivity measurements and cognitive impairment and 
its performance as a diagnostic variable. We found that 
out-strength, a measure related to effective connectivity, in 
the right occipito-parietal region (ROI 7) is related to age, 
and hence to neurodegenerative process, in individuals 
carrying the PSEN1 E280A mutation. The fact that this 
relationship is only present in the aforementioned group 
of individuals indicates that the measurement could be 
related to the neurodegenerative process. By analyzing the 
temporal behavior of measurements in ROI 7, we found 
that in the 500-600 ms period it is possible to differentiate 
between ACr and Control1 groups with 67 % sensitivity and 
80 % specificity, and between the MCI and Control2 groups 
with 83 % sensitivity and 67 % specificity. 
Table 4. Individual AUROCs. Table lists the area under the ROC cur-
ves and confidence intervals for the ten time windows where differen-
ces between ACr patients and Control1 subjects, and MCI patients and 
Control2 subjects were found. For each ROC curve, we select the best 
cut-off point (threshold) for out-strength and calculated the respective 




AUROC CI Threshold Sensitivity Specificity PPV NPV
0–100 0,57 0,35-0,79 0,37 0,47 0,87 0,78 0,62
100–200 0,53 0,31-0,75 -0,14 0,67 0,53 0,59 0,62
200–300 0,52 0,29-0,74 -0,03 0,67 0,53 0,59 0,62
300–400 0,72 0,52-0,91 -0,35 0,93 0,53 0,67 0,89
400–500 0,68 0,47-0,88 -0,17 0,80 0,53 0,63 0,73
500–600 0,71 0,51-0,90 0,13 0,67 0,80 0,77 0,71
600–700 0,64 0,43-0,85 0,14 0,53 0,80 0,73 0,63
700–800 0,66 0,45-0,86 0,30 0,40 0,93 0,86 0,61
800–900 0,70 0,49-0,91 0,18 0,60 0,93 0,90 0,70




AUROC CI Threshold Sensitivity Specificity PPV NPV
0–100 0,62 0,37-0,86 -0,27 0,58 0,75 0,70 0,64
100–200 0,48 0,23-0,73 0,12 0,42 0,75 0,63 0,56
200–300 0,44 0,19-0,70 0,16 0,50 0,75 0,67 0,60
300–400 0,44 0,19-0,68 0,02 0,50 0,58 0,55 0,54
400–500 0,66 0,43-0,89 -0,15 0,58 0,75 0,70 0,64
500–600 0,76 0,56-0,96 0,07 0,83 0,67 0,71 0,80
600–700 0,59 0,35-0,83 0,16 0,83 0,42 0,59 0,71
700–800 0,67 0,44-0.90 -0,22 0,58 0,75 0,70 0,64
800–900 0,61 0,37-0,85 -0,36 0,42 0,92 0,83 0,61
900-1000 0,56 0,31-0,80 0,03 0,67 0,58 0,62 0,64
AUROC: area under the ROC curve; CI: confidence interval; PPV: po-
sitive predictive value; NPV: negative predictive value.
Figure 3. Out-strength mean for each group in ROI 7. How the con-
nectivity is estimated in time windows of 100−ms, the plot shows how 
the connectivity changes for each time window across the 1−s epoch. 
The rectangle refers to the time interval in which out-strength presen-
ted statistically significant differences. ACr: asymptomatic mutation 
carriers; MCI: Mild Cognitive Impairment; Control1 and Control2: 
non-carriers.
Table 4 describes the AUROC analysis for the intervals 
of out-strength in ROI 7. The table includes a threshold 
for each variable where both sensitivity and specificity 
are higher (best cut-off). The best diagnosis interval was 
(500 – 600) ms comparing both ACr and Control1, and MCI 
and Control2 groups, which presented the highest AUROC 
values. 
Table 3. Results of Correlation analysis for out-strength connectivity 
in carriers and non-carriers.
ROI
Carriers Noncarriers
Age MMSE Age MMSE
CC P-value CC P-value CC P-value CC P-value
1 −0,29 0,14 0,011 0,95 −0,051 0,8 −0,3 0,13
2 −0,027 0,89 −0,12 0,54 −0,23 0,25 −0,05 0,8
3 −0,21 0,29 0,36 0,066 −0,005 0.,8 −0,039 0,85
4 −0,42 0,031 0,38 0,05 −0,093 0,64 −0,18 0,37
5 −0,25 0,21 0,14 0,49 0,20 0,31 0,26 0,18
6 −0,24 0,22 0,072 0,72 0,19 0,34 −0,063 0,76
7 −0,54 0,0036 0,37 0,058 −0,016 0,94 −0,059 0,77
8 −0,11 0,58 −0,054 0,79 0,11 0,59 0,26 0,19
ROI: region of interest; CC: correlation coefficient.
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Previous studies of PSEN1 E280A mutation using EEG have 
shown an alteration in brain function in presymptomatic 
disease cases. By estimating intracranial sources of 
evoked potentials (ERPs), lower N400 amplitudes 
were found in symptomatic carriers compared with 
presymptomatic carriers and non-carriers. In addition, 
the topography differed in the mutation carrier group 
with respect to the non-carriers (Bobes et al., 2010). 
Other ERPs study, which examines dynamic brain 
function in young presymptomatic carriers in a visual 
recognition process, found that despite an identical 
behavioral performance, the carriers showed lower 
positivity in frontal regions and increased positivity in 
occipital regions compared with control subjects. These 
differences were more pronounced during the (200-
300) ms period. Discriminant analysis at this time interval 
showed promising sensitivity (72,7 %) and specificity 
(81,8 %) for predicting the presence of AD (Y T Quiroz 
et al., 2011). 
Brain activity in the occipital region has been associated 
with visual perceptual processing (Cronin-Golomb, 
Gilmore, Neargarder, Morrison, & Laudate, 2007). AD 
is thought to cause a functional decline associated with 
posterior cortical dysfunction, and a variety of visual 
disorders including impairments of contrast sensitivity, 
motion perception and navigation. In fact, navigation has 
been associated with memory problems observed in AD 
(Ally, McKeever, Waring, & Budson, 2009). The pattern 
of posterior connectivity observed in the ACr group may 
reflect an early AD-related synaptic dysfunction or a 
neural compensation process that requires that carriers 
use posterior regions more in recognition memory in 
order to perform equally well as the controls. A positron 
emission tomography study by Fleisher et al, (2015) found 
that, compared with non-carriers, cognitively unimpaired 
PSEN1 E280A mutation carriers have significantly 
lower precuneus cerebral metabolic rates for glucose. 
The reduction in brain metabolism and atrophy may be 
reflected by an increment in functional connectivity. 
Evidences about connectivity changes that might be related 
to increased neuronal activity, as a possible compensatory 
mechanisms, were found using fMRI (Yakeel T Quiroz et 
al., 2010), and EEG (Ochoa et al., 2015).
Here we found that connectivity in MCI carrier patients 
decreases compared with the other groups. The MCI group 
presents an initial state of the neurodegenerative process 
of dementia with a loss of cognitive functions (MMSE 
significantly lower compared with Control2). Connectivity 
studies with EEG have shown a reduced synchronization in 
sporadic AD and MCI patients for delta and beta bands, and 
a progressive decrease in alpha1 synchronization through 
the disease states (Babiloni et al., 2006). Our results suggest 
that the decrease in connectivity in MCI carriers could occur 
by this loss of synchronization during the progression of 
the disease, and that in this state, the dynamics of EEG are 
similar in PSEN1 E280A mutation carriers and sporadic AD.
Overall, our results are consistent with connectivity and 
ERP studies and show that EEG connectivity measurements 
could be used as markers for the detection and monitoring 
of AD in PSEN1 E280A mutation carriers. Compared to ERPs 
analysis, which are mainly based on averages of the signal, 
the study of graph functional connectivity is an alternative 
for a more systematic analysis of the brain, where a measure 
may represent important information about both local and 
global organization of brain functioning.
Conclusions
The order and magnitude of pathological processes in AD 
are not well understood, partly because of the lack of an 
early diagnostic tool that enables the study of the evolution 
of the disease. Autosomal dominant Alzheimer’s disease 
has a predictable age at onset and provides an opportunity 
to determine the sequence and magnitude of pathological 
changes that culminate in symptomatic disease. Our 
results show that effective connectivity is related to 
age in the carrier group and therefore may be related to 
neurodegenerative processes. This provides an opportunity 
to test new biomarkers in AD. The next step is to study 
the evolution of the proposed effective connectivity in a 
longitudinal study.
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code PRG14-1-02.
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